Rovin Capital Oncolytics Biotech Inc Transaction History
Rovin Capital
- $278 Million
- Q4 2024
A detailed history of Rovin Capital transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Rovin Capital holds 20,620 shares of ONCY stock, worth $12,990. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,620
Previous 20,620
-0.0%
Holding current value
$12,990
Previous $18,000
5.56%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ONCY
# of Institutions
47Shares Held
1.3MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL200KShares$126,2520.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$119,6620.05% of portfolio
-
Goldman Sachs Group Inc New York, NY101KShares$63,8800.0% of portfolio
-
Virtu Financial LLC New York, NY98.5KShares$62,0240.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.9KShares$42,1710.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $36.5M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...